Income Tax Department carries out survey proceedings at Ipca Labs Mumbai, Sikkim plant
Mumbai: Ipca Labs has informed in a recent BSE filing that the Income Tax Department has carried out survey proceedings at the Company’s offices in Mumbai and at Sikkim manufacturing plants between 30th May, 2023 to 3rd June, 2023."The Company has extended its full co-operation and support to the Officials of the Income Tax Department during their survey proceedings and has provided...
Mumbai: Ipca Labs has informed in a recent BSE filing that the Income Tax Department has carried out survey proceedings at the Company’s offices in Mumbai and at Sikkim manufacturing plants between 30th May, 2023 to 3rd June, 2023.
"The Company has extended its full co-operation and support to the Officials of the Income Tax Department during their survey proceedings and has provided timely and correct information/data asked for and shall continue to provide any further details/information that might be required by the department in future," Ipca stated.
Read also: Ipca Labs to buy 33 percent stake in Unichem Labs for 1,034 crore
Ipca Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. The company was founded by group of businessmen and medical professionals in 1949. It produces theobromine, acetyl thiophene, and p-bromotoluene as active pharmaceutical ingredients (APIs). Ipca sells these APIs and their intermediates globally. Ipca is a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments.
Read also: IPCA Lab gets CDSCO panel nod for phase 3 trial of HCQ as add-on therapy in type 2 diabetes
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd